Organovo Inc. (ONVO)
2.12
-0.05 (-2.30%)
At close: Apr 04, 2025, 3:59 PM
2.06
-3.04%
After-hours: Apr 04, 2025, 07:00 PM EDT
-2.30% (1D)
| Bid | 1.75 |
| Market Cap | 3.61M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -10.08 |
| PE Ratio (ttm) | -0.21 |
| Forward PE | -0.47 |
| Analyst | n/a |
| Ask | 2.38 |
| Volume | 60,167 |
| Avg. Volume (20D) | 670,843 |
| Open | 2.04 |
| Previous Close | 2.17 |
| Day's Range | 1.96 - 2.12 |
| 52-Week Range | 1.96 - 21.96 |
| Beta | 1.13 |
About ONVO
Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive h...
Industry Biotechnology
Sector Healthcare
IPO Date Feb 14, 2012
Employees 14
Stock Exchange NASDAQ
Ticker Symbol ONVO
Website https://www.organovo.com
Next Earnings Release
Organovo Inc. is scheduled to release its earnings on May 30, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 weeks ago
-32.67%
Organovo shares are trading lower after the compan...
Unlock content with
Pro Subscription
1 month ago
+313.01%
Organovo shares are trading higher after the company announced that Eli Lilly is set to acquire its FXR program, including FXR314.
